| Literature DB >> 35091634 |
Jin Myoung Seok1, Wanzee Cho2, Doo-Hwan Son3, Jong Hwa Shin4,5, Eun Bin Cho6,7, Sung Tae Kim8, Byoung Joon Kim4,5, Joon-Kyung Seong9,10,11, Ju-Hong Min12,13,14.
Abstract
Although fatigue is a major symptom in patients with neuromyelitis optica spectrum disorder (NMOSD), the underlying mechanism remains unclear. We explored the relationship between subcortical structures and fatigue severity to identify neural substrates of fatigue in NMOSD. Clinical characteristics with brain magnetic resonance imaging were evaluated in forty patients with NMOSD. Fatigue was assessed using the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-fatigue) questionnaire (a higher score indicates less fatigue). We assessed the correlation between subcortical structures and fatigue severity using surface-based shape analysis. Most of the enrolled patients showed fatigue (72.5%; mean FACIT-fatigue score, 34.8 ± 10.8). The FACIT-fatigue score was negatively correlated with Expanded Disability Status Scale and Beck Depression Inventory scores (r = - 0.382, p = 0.016; r = - 0.578, p < 0.001). We observed that the right thalamus was the only extracted region for various threshold experiments. Further, patients with lower FACIT-fatigue scores (more fatigue) had decreased local shape volume in the right thalamus. Fatigue is common in patients with NMOSD, and atrophy in the right thalamus is strongly correlated with fatigue severity. The local shape volume of the right thalamus might serve as a biomarker of fatigue in NMOSD.Entities:
Mesh:
Year: 2022 PMID: 35091634 PMCID: PMC8799731 DOI: 10.1038/s41598-022-05531-1
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Clinical characteristics of enrolled patients with neuromyelitis optica spectrum disorder.
| Enrolled patients with NMOSD | |
|---|---|
| Age, years (SD) | 47.8 (12.4) |
| Female, n (%) | 32 (80.0) |
| AQP4 antibody, n (%) | 34 (85.0) |
| Disease duration, years (IQR) | 2.9 (1.1–7.1) |
| EDSS (SD) | 2.8 (2.3) |
| Number of relapses (IQR) | 2 (1 − 4) |
| Optic neuritis, n (%) | 24 (60.0) |
| Transverse myelitis, n (%) | 23 (57.5) |
| Area of postrema syndrome, n (%) | 4 (10.0) |
| Brainstem syndrome, n (%) | 16 (40.0) |
| Cerebral syndrome, n (%) | 13 (32.5) |
| Azathioprine, n (%) | 12 (30.0) |
| Mycophenolate mofetil, n (%) | 18 (45.0) |
| Rituximab, n (%) | 4 (10.0) |
| Oral prednisolone, n (%) | 1 (2.5) |
| No treatment, n (%) | 4 (10.0) |
| Other‡, n (%) | 1 (2.5) |
| FACIT-fatigue score, (SD) | 34.8 (10.8) |
| Beck Depression Inventory score, (SD) | 14.1 (8.5) |
NMOSD neuromyelitis optica spectrum disorder, SD standard deviation, IQR interquartile range, AQP4 Aquaporin-4, FACIT-fatigue Functional Assessment of Chronic Illness Therapy-fatigue.
†Onset attacks are included.
‡Eculizumab (n = 1) was used for preventive treatment.
Figure 1Scatter plots depicting correlation among disease duration, EDSS, BDI, and FACIT-fatigue. The FACIT-fatigue score was negatively correlated with EDSS and BDI scores; however, no correlation was observed between the FACIT-fatigue score and disease duration.
Figure 2Significant regions related with FACIT-fatigue score at a threshold of 0.35. The area of decreased local shape volume correlated with FACIT-fatigue score involved the right thalamus in patients with NMOSD.
Figure 3Overview of the proposed method. (A) Subcortical shape analysis, (B) statistical analysis using cluster-based statistics and visualising statistically significant subnetworks for each subcortical region.